Yahoo Web Search

Search results

    • FDA clears GSK's RSV vaccine for adults ages 50-59

      FDA clears GSK's RSV vaccine for adults ages 50-59

      United Press International via Yahoo News· 13 hours ago

      The U.S. Food and Drug Administration on Friday approved GSK's respiratory syncytial virus vaccine for high-risk adults ages 50 to 59, expanding the...

    • FDA Reverses Juul Ban. What Comes Next?

      FDA Reverses Juul Ban. What Comes Next?

      InvestorPlace· 2 days ago

      The FDA lifted its ban on Juul’s products after conducting additional studies of the products. Also flavoring the FDAs</ ...